Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 22, 2019

#ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

  • MS Research Study and Reports
    /
  • Tysabri
    /
Click here to subscribe to the MS Beacon e-Newsletter by MS Views and News   Continuing Tysabri (natalizumab) treatment up to week 28…
MS Research Study and Reports

September 22, 2019

Ponesimod Bests Aubagio in Head-to-Head MS Trial

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Investigational drug reduces annual relapse rate, shows effects on fatigue by Judy George, Senior Staff Writer, MedPage TodaySeptember 12, 2019 STOCKHOLM —…
MS Drug Therapies

September 22, 2019

#ECTRIMS2019 – Data Shows Ublituximab’s Long-term Safety in Relapsing MS, TG Therapeutics Announced

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
EXPERIMENTAL TREATMENTS FOR MS » UBLITUXIMAB (TGTX-1101) Ublituximab (TGTX-1101) is a glycoengineered anti-CD20 monoclonal antibody being developed by TG Therapeutics  as a potential treatment for relapsing…
MS Drug Therapies

September 21, 2019

Handling Stress – Mind-Body Basics for People with MS

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Learning how to get a handle on stress (so it doesn’t manhandle you!) not only helps you manage multiple sclerosis…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 21, 2019

New Study Shows Why Myelin Repair May Fall Short in MS

  • MRI
    /
  • MS Research Study and Reports
    /
Inflammation Can Hijack Brain Repair Cells to Ramp Up Immune Attacks in MS, Researchers Report 09.04.19 Society-funded researchers discover that…
MRI

September 16, 2019

Economic Factors Amplify Burden of Disease for Patients With Multiple Sclerosis

  • Multiple Sclerosis
    /
Sept 2019 While economic issues differ across countries and healthcare systems, a universal concern is that multiple sclerosis (MS) is…
Multiple Sclerosis

September 13, 2019

Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis

  • MS Drug Therapies
    /
  • Ocrevus
    /
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– – Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in…
MS Drug Therapies

September 12, 2019

Genentech’s Satralizumab Significantly Reduced Relapse Risk in Second Positive Phase III Study for Neuromyelitis Optica Spectrum Disorder

  • NMO (NMOSD/Devics)
    /
Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at…
NMO (NMOSD/Devics)

September 11, 2019

Music Therapy for MS: How Rhythm Can Help With Movement and Memory

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Music and rhythm can improve the brain’s ability to function and the body’s ability to move. By David Spero, RN…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 10, 2019

How MS Affects Sleep Quality – Plus: Sleep Tips for People with Multiple Sclerosis

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Article originally published on Mattress Advisor Do you ever feel like your energy levels disappear during the day? If so,…
Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts